|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-1-16
|
|
pubmed:abstractText |
Human T-cell lymphotropic virus type I and II (HTLV-I and II) are human retroviruses that can be transmitted by transfusion of whole blood. An HTLV-I infection is associated with adult T-cell leukaemia (ATL) and with tropical spastic paraparesis (TSP). Antibody tests from 5.5 million European blood donors have shown that the HTLV prevalence is low, ranging from 0 to 0.02%. This paper examines costs and effects associated with the intervention of testing all new blood donors for HTLV.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-5771
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1076-84
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11101551-Blood Donors,
pubmed-meshheading:11101551-Blood Transfusion,
pubmed-meshheading:11101551-Cost-Benefit Analysis,
pubmed-meshheading:11101551-HIV Seroprevalence,
pubmed-meshheading:11101551-HTLV-I Infections,
pubmed-meshheading:11101551-HTLV-II Infections,
pubmed-meshheading:11101551-Humans,
pubmed-meshheading:11101551-Models, Statistical,
pubmed-meshheading:11101551-Norway,
pubmed-meshheading:11101551-Quality-Adjusted Life Years,
pubmed-meshheading:11101551-Sensitivity and Specificity,
pubmed-meshheading:11101551-Seroepidemiologic Studies
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
|
|
pubmed:affiliation |
Department of Population Health Sciences, National Institute of Public Health, Oslo, Norway. Hein.Stigum@Folkehelsa.no
|
|
pubmed:publicationType |
Journal Article
|
